WEX Pharmaceuticals Inc. ("WEX" or the "Company") (TSX:WXI) advises that there
has been no material change in the information contained in its Notice of
Default dated August 17, 2007.


In compliance with regulatory requirements, WEX is disseminating and filing on
SEDAR the attached Default Status Report.


About WEX Pharmaceuticals Inc.

WEX Pharmaceuticals Inc. is dedicated to the discovery, development, manufacture
and commercialization of innovative drug products to treat pain. The Company's
principal business strategy is to derive drugs from naturally occurring toxins
and develop proprietary products for the global market. The Company's Chinese
subsidiary sells generic products manufactured at its facility in China.


Forward Looking Statements and Information

This News Release contains forward-looking statements which may not be based on
historical fact. Such forward-looking statements involve known and unknown
risks, uncertainties and other factors that may cause the actual results, events
or developments to be materially different from any future results, events or
developments expressed or implied by such forward-looking statements. These
factors should be considered carefully and readers are cautioned not to place
undue reliance on such forward-looking statements. The company disclaims any
obligation to update any such factors or to publicly announce the result of any
revisions to any of the forward-looking statements contained herein to reflect
future results, events or developments.


DEFAULT STATUS REPORT

1. WEX Pharmaceuticals Inc. ("WEX") advises that there has been no material
change in the information contained in its Notice of Default dated August 17,
2007.


2. WEX expects to file its interim financial statements for its first fiscal
quarter ended June 30, 2007 by October 14, 2007 as contemplated in the Notice of
Default.


3. There is no other material information concerning the affairs of WEX that has
not been generally disclosed as of the date hereof.


Dated the 29th day of August, 2007.

WEX PHARMACEUTICALS INC.

Edge Wang, Authorized Signatory
Western Exploration (TSXV:WEX)
Historical Stock Chart
From Feb 2025 to Mar 2025 Click Here for more Western Exploration Charts.
Western Exploration (TSXV:WEX)
Historical Stock Chart
From Mar 2024 to Mar 2025 Click Here for more Western Exploration Charts.